In the present work, polydopamine (PDA) modified reduced graphene oxide (pRGO)/SnO 2 /Au nanoparticles (NPs) were synthesized.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: